Age-related changes of the cervix influence human papillomavirus type distribution

被引:90
作者
Castle, PE
Jeronimo, J
Schiffman, M
Herrero, R
Rodríguez, AC
Bratti, MC
Hildesheim, A
Wacholder, S
Long, LR
Neve, L
Pfeiffer, R
Burk, RD
机构
[1] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA
[2] Natl Lib Med, Commun Engn Branch, NIH, Bethesda, MD 20892 USA
[3] Fdn INCIENSA, Proyecto Epidemiol Guanacaste, San Jose, Costa Rica
[4] Albert Einstein Coll Med, New York, NY USA
关键词
D O I
10.1158/0008-5472.CAN-05-3066
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Approximately 15 human papillomavirus (HPV) types cause virtually all cervical cancer whereas other HPV types are unrelated to cancer. We were interested in whether some noncarcinogenic types differ from carcinogenic in their affinity for the cervical transformation zone, where nearly all HPV-induced cancers occur. To examine this possibility, we tested cervical specimens from 8,374 women without cervical precancer and cancer participating in a population-based study in Guanacaste for > 40 HPV types using PCR. We compared age-group specific prevalences of HPV types of the alpha 9 species, which are mainly carcinogenic and include HPV16, to the genetically distinct types of the alpha 3/alpha 15 species (e.g., HPV71), which are noncarcinogenic and common in vaginal specimens from hysterectomized women. We related HPV detection of each group to the location of the junction between the squamous epithelium of the ectocervix and vagina and the columnar epithelium of the endocervical canal. Models evaluated the independent effects of amount of exposed columnar epithelium (ectopy) and age on the presence of alpha 9 or alpha 3/alpha 15 types. Prevalence of alpha 9 types (7.6%) peaked in the youngest women, declined in middle-aged women, and then increased slightly in older women. By contrast, prevalence of alpha 3/alpha 15 types (7.6%) tended to remain invariant or to increase with increasing age. Detection of alpha 9 infections increased (P-trend < 0.0005) but alpha 3/alpha 15 infections decreased (Ptrend < 0.0005) with increasing exposure of the columnar epithelia. Older age and decreasing cervical ectopy were independently positively associated with having an alpha 3/alpha 15 infection compared with having an alpha 9 infection. These patterns need to be confirmed in other studies and populations. We suggest that these genetically distinct groups of HPV types may differ in tissue preferences, which may contribute to their differences in carcinogenic potential.
引用
收藏
页码:1218 / 1224
页数:7
相关论文
共 36 条
  • [1] Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United States
    Altekruse, SF
    Lacey, JV
    Brinton, LA
    Gravitt, PE
    Silverberg, SG
    Barnes, WA
    Greenberg, MD
    Hadjimichael, OC
    McGowan, L
    Mortel, R
    Schwartz, PE
    Hildesheim, A
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 188 (03) : 657 - 663
  • [2] E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I
    Ashrafi, GH
    Haghshenas, MR
    Marchetti, B
    O'Brien, PM
    Campo, MS
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 113 (02) : 276 - 283
  • [3] IDENTIFICATION AND ASSESSMENT OF KNOWN AND NOVEL HUMAN PAPILLOMAVIRUSES BY POLYMERASE CHAIN-REACTION AMPLIFICATION, RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS, NUCLEOTIDE-SEQUENCE, AND PHYLOGENETIC ALGORITHMS
    BERNARD, HU
    CHAN, SY
    MANOS, MM
    ONG, CK
    VILLA, LL
    DELIUS, H
    PEYTON, CL
    BAUER, HM
    WHEELER, CM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (05) : 1077 - 1085
  • [4] PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE
    BOSCH, FX
    MANOS, MM
    MUNOZ, N
    SHERMAN, M
    JANSEN, AM
    PETO, J
    SCHIFFMAN, MH
    MORENO, V
    KURMAN, R
    SHAH, KV
    ALIHONOU, E
    BAYO, S
    MOKHTAR, HC
    CHICAREON, S
    DAUDT, A
    DELOSRIOS, E
    GHADIRIAN, P
    KITINYA, JN
    KOULIBALY, M
    NGELANGEL, C
    TINTORE, LMP
    RIOSDALENZ, JL
    SARJADI
    SCHNEIDER, A
    TAFUR, L
    TEYSSIE, AR
    ROLON, PA
    TORROELLA, M
    TAPIA, AV
    WABINGA, HR
    ZATONSKI, W
    SYLLA, B
    VIZCAINO, P
    MAGNIN, D
    KALDOR, J
    GREER, C
    WHEELER, C
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11): : 796 - 802
  • [5] Bratti MC, 2004, REV PANAM SALUD PUBL, V15, P75
  • [6] A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women
    Brown, DR
    Shew, ML
    Qadadri, B
    Neptune, N
    Vargas, M
    Tu, WZ
    Juliar, BE
    Breen, TE
    Fortenberry, JD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (02) : 182 - 192
  • [7] A population-based study of vaginal human papillomavirus infection in hysterectomized women
    Castle, PE
    Schiffman, M
    Bratti, MC
    Hildesheim, A
    Herrero, R
    Hutchinson, ML
    Rodriguez, AC
    Wacholder, S
    Sherman, ME
    Kendall, H
    Viscidi, RP
    Jeronimo, J
    Schussler, JE
    Burk, RD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (03) : 458 - 467
  • [8] Castle PE, 2002, CANCER EPIDEM BIOMAR, V11, P1394
  • [9] Comparisons of HPV DNA detection by MY09/11 PCR methods
    Castle, PE
    Schiffman, M
    Gravitt, PE
    Kendall, H
    Fishman, S
    Dong, H
    Hildesheim, A
    Herrero, R
    Bratti, MC
    Sherman, ME
    Lorincz, A
    Schussler, JE
    Burk, RD
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2002, 68 (03) : 417 - 423
  • [10] Carcinogenicity of human papillomaviruses
    Cogliano, V
    Baan, R
    Straif, K
    Grosse, Y
    Secretan, B
    El Ghissassi, F
    [J]. LANCET ONCOLOGY, 2005, 6 (04) : 204 - 204